Pharmafile Logo
Pharmafocus logo
Advanced Search
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

February 3, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

Moving into February,and the first weeks of Trump’s term, the US President has dominated the headlines in the industry as …

News
pills

Study reveals antidepressant medication’s action upon brain

February 3, 2017
Medical Communications, Research and Development antidepressants, mental health, research

With levels of antidepressant prescription rising coupled with the lack of development and investment in new treatments, further research into …

News
shutterstock_57369385

WCO seizes 113m fake Indian & Chinese drugs in Africa in 10 days

February 3, 2017
Manufacturing and Production, Medical Communications, Sales and Marketing Africa, China, Counterfeit drugs, India, World Customs Organisation

The World Customs Organisation (WCO) has revealed insight into the extent of the global drug counterfeiting crisis with the announcement …

News

NICE rejects Pfizer’s first-in-class breast cancer drug

February 3, 2017
Medical Communications, Sales and Marketing NICE, Pfizer, breast cancer

NICE has published draft guidelines which reject Pfizer’s Ibrance (palbociclib) based primarily on the cost of the drug but also …

News

Cirrus ready for serialisation pack changes

February 2, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cirrus, Multi Packaging Solutions

Cirrus, a Multi Packaging Solutions company, offers a full artwork management service ahead of enforced pack changes due to impending …

News
Press release
heart_rope

More at risk of sudden death due to faulty heart gene than thought

February 2, 2017
Medical Communications, Research and Development British Heart Foundation, faulty gene, sudden death

The British Heart Foundation has revealed that around 620,000 people are thought to be at risk of having a faulty …

News
insider_interview_headshots_2016_overview

2016: A retrospective from the industry

February 2, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

2016 was characterised by some of the biggest political shifts in recent times. We ask four major pharma figures for …

Feature

Pakistan drug regulatory body “a complete failure” according to officials

February 2, 2017
Sales and Marketing Drug Regulatory Authority of Pakistan, Pakistan, Sania Nishtar

Key figures in the Pakistani pharmaceutical industry are calling for review of the Drug Regulatory Authority of Pakistan (DRAP) over …

News
syringe-1973129_960_720

‘Last-resort’ antibiotic-resistant bacteria found along 4km of Chinese coastline

February 2, 2017
Medical Communications, Research and Development

Recent research has been published that reveals that a four kilometre stretch of coastline in China harboured bacteria resistant to …

News
allerganlogo

Allergan successfully completes $2.9bn LifeCell acquisition

February 2, 2017
Business Services, Sales and Marketing Allergan, LifeCell

The acquisition of regenerative medicine firm LifeCell by Allergan for $2.9 billion announced back in December has been completely successfully, …

News

Two-decade-long prostate cancer study finds antiandrogen improves survival

February 2, 2017
Research and Development antiandrogen, oncology, prostate cancer

Research conducted over the course of two decades has found a positive correlation between overall survival in prostate cancer patients …

News
rick_fair

Genentech oncology head leaves for Bellicum CEO role

February 1, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bellicum, Genentech, Roche, tecentriq

Bellicum Pharmaceuticals has snatched up Genentech’s Rick Fair as its new CEO and President. Fair moves to Bellicum from Genentech …

Appointment
msd_merck_night_building

MSD’s drug given European approval for first-line treatment in NSCLC

February 1, 2017
Sales and Marketing European Commission, MSD, Merck

The good news keeps coming for MSD, known as Merck in North America, and Keytruda, with a further label expansion …

News

Sanofi & Regeneron’s arthritis drug scores first approval following FDA rejection

February 1, 2017
Research and Development, Sales and Marketing Actemra, Humira, Kevzara, Regeneron, Roche, Sanofi, sarilumab

Kevzara (sarilumab), a interleukin-6 (IL06) receptor antibody developed by Sanofi and Regeneron and the first real competitor to Roche’s Actemra …

News
pills_spill

Potential treatment for opioid withdrawal discovered

February 1, 2017
Medical Communications, Research and Development University of Calgary, gout, opioid

Researchers from the University of Calgary have found that medication used to treat gout could also lessen the side-effects experienced …

News
fda2outsideweb

Italian firm warned by FDA over record-shredding and drug quality misrepresentation

February 1, 2017
Manufacturing and Production, Research and Development FACTA Farmaceutici, FDA

Italian drug manufacturer FACTA Farmaceutici has been issued a warning letter by the FDA after being found shredding “critical laboratory …

News
immunisation

African Heads of State commit to universal access to immunisation

February 1, 2017
Medical Communications, Research and Development Africa, Vaccine, WHO, immunisation

The Heads of State convened from across Africa to ratify the Addis Declaration on Immunization (ADI). The pledge commits to …

News
donald_trump_september_3_2015

Trump meets with top pharma execs, reiterates pledge to lower “astronomical” prices

January 31, 2017
Manufacturing and Production, Research and Development, Sales and Marketing Celgene, Eli Lilly, Novartis, PhRMA, Trump

President Trump convened with a number of top pharma execs at the White House on Tuesday to discuss the key …

News
mylan_plus_hero_720x510_1

Antitrust investigation into Mylan begins over EpiPen

January 31, 2017
Research and Development, Sales and Marketing Mylan, pricing

The Federal Trade Commission has submitted a request to Mylan for information as part of a preliminary investigation into whether …

News
anopheles_albimanus_mosquito_web

First-line malaria treatment fails for the first time in UK

January 31, 2017
Manufacturing and Production, Research and Development UK, malaria

The key combination malaria therapy artemether-lumefantrine has failed to treat UK patients for the first time, suggesting that the parasite …

News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026